Case Study: Delivering Early Enrollment Against Aggressive Timelines in a Phase II Parkinson’s Disease Study
How a Site-Centric Delivery Model Accelerated Study Start-Up When a Phase II Parkinson’s disease study faced aggressive start-up and enrollment targets, the study team was tasked with achieving first patient consent within just eight weeks of f...